Creating affordable radiopharmaceuticals for medical imaging and therapy
Production of radiometal-based radiopharmaceuticals at a clinical scale via droplet-scale radiochemistry
This study is working on a new, cheaper way to make special medicines used in medical imaging and treatment, so more patients can easily get the care they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dropletpharm INC. NIH-funded |
| Lab location | 1 site (Sherman Oaks, United States) |
| Project ID | NIH-10697509 on NIH RePORTER |
What this research studies
This research focuses on developing a more cost-effective method for producing radiopharmaceuticals, which are essential for imaging and therapy in nuclear medicine. By utilizing droplet-scale radiochemistry, the project aims to reduce the expensive infrastructure currently required for production, making these valuable compounds more accessible. The approach seeks to enable batch production that can serve multiple patients, thereby lowering the cost per dose and increasing the availability of various radiopharmaceuticals. This could enhance both clinical applications and research opportunities in the field.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients requiring imaging or therapy using radiopharmaceuticals, particularly those who may benefit from less commonly used tracers.
Not a fit: Patients who do not require radiopharmaceuticals for imaging or therapy will likely not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly lower the costs of radiopharmaceuticals, making them more accessible for patients and improving diagnostic and therapeutic options.
How similar studies have performed: While the approach of droplet-scale radiochemistry is innovative, similar efforts to reduce production costs in radiopharmaceuticals have shown promise in other contexts.
Where this research is happening
Sherman Oaks, United States
- Dropletpharm INC. — Sherman Oaks, United States (Active)
Researchers
- Principal investigator: Jones, Jason — Dropletpharm INC.
- Study coordinator: Jones, Jason
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.